AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06002139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality Therapy
Description: 8 sessions of VR therapy over 4 weeks (each of them 20 minutes long).~As a virtual reality source, VRTierOne device (Stolgraf®) were used. Thanks to using head mounted display and the phenomenon of total immersion VR therapy provides an intense visual, auditory and kinesthetic stimulation. It can have a calming and mood-improving effect or help the patients recognize their psychological resources and motivate to the rehabilitation process. In the virtual therapeutic garden there are a rich set of symbols and metaphors based on Ericksonian Psychotherapy approach. The most important is the Garden of Revival which symbolizes the patient's health. It used to be full of life and energy, now it is neglected, requires work to be revived. In the therapeutic process day by day, the therapist tells the patient a symbolic story about his/her situation.
Study NCT06002139 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: Four weeks of conventional rehabilitation including:~* Two hours of kinesiotherapy (120 minutes, including gait training).~* Thirty minutes of ergotherapy.~* Three physical therapy procedures (i.e. laser therapy, magnetic therapy, electrotherapy) tailored to individual ailments and needs.
Study NCT06002139 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation
Description: Four weeks of conventional rehabilitation including:~* Two hours of kinesiotherapy (120 minutes, including gait training).~* Thirty minutes of ergotherapy.~* Three physical therapy procedures (i.e. laser therapy, magnetic therapy, electrotherapy) tailored to individual ailments and needs.
Study NCT05032274 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based Exercise Program
Description: The exercise program will include chink tuck and shoulder retraction exercises. The chin tuck exercise will be performed in standing position. The shoulder retraction exercise includes activation and strengthening components. The activation component will be performed in standing position and strengthening component will be performed in prone position.
Study NCT05274581 — intervention group
Intervention type: OTHER
Intervention: A new type of ultrasound course
Description: All participants will receive the educational intervention. The educations intervention consists of three teaching seminars over three months, a curriculum of 10 point-of-care ultrasound applications, an online learning platform providing educational support before, during and after the teaching sessions.
Study NCT06284395 — intervention group
Intervention type: DRUG
Intervention: Bortezomib
Description: Bortezomib 1.3mg/m2 SC on days 1,4, 8,11 to the TD scheme for a total of 6 treatment cycles (14,15) (VTD)
Study NCT06523907 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Basic Nursing skills
Description: Evaluating the effectiveness of the education program in improving paramedics' knowledge of essential nursing care principles, such as hygiene practice, infection control, safe administration of injection, blood draw, vital sign monitoring, respiratory rate
Study NCT06523907 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Present Knowledge about basic nursing skill
Description: Assess the current and baseline knowledge status of the participants about the hygiene practice, infection control, safe administration of injection, blood draw, vital sign monitoring, respiratory rate
Study NCT04611867 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supportive application with integrated weekly PRO
Description: Patients will fill in a web-based application PRO-CTCAE with integrated preparation questionnaire every week. If their weekly reported symptoms exceed a predefined threshold of severity, this results in a notification on the staff application interface and a nurse will contact a patient for verification of symptoms. Nurse will review patient recent treatment and PRO reports and advise patient according to the local practice for symptom management and reinforce reporting. Nurse will consult with or refers to (if possible) treating physician if patient will require medical intervention and/or physician assistance.
Study NCT06630078 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wevosys acoustic analysis
Description: Recording of voice signal of subjects enrolled
Study NCT05296954 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: high resolution cartography
Description: High-resolution electro-anatomical mapping will be performed in each group with the RHYTHMIA HDx system to obtain an activation and voltage map of the Koch triangle and surrounding areas.
Study NCT05296954 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: high resolution cartography
Description: High-resolution electro-anatomical mapping will be performed in each group with the RHYTHMIA HDx system to obtain an activation and voltage map of the Koch triangle and surrounding areas.
Study NCT06390774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SSGJ-705
Description: anti-PD-1 and anti-HER2 bispecific antibody
Study NCT04733937 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: a2 Platinum® stage 1 infant formula
Description: Upon randomization (if not included in the breastfed group), each participant will be provided with up to 105 days' supply of the standardized formula and up to 28 days' supply of the allocated formula. Participants and study investigators will conduct the trial via a pre-determined randomization schedule.
Study NCT04733937 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional, A1 and A2 β-casein containing stage 1 infant formula
Description: Upon randomization (if not included in the breastfed group), each participant will be provided with up to 105 days' supply of the standardized formula and up to 28 days' supply of the allocated formula. Participants and study investigators will conduct the trial via a pre-determined randomization schedule.
Study NCT05564026 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Questionnaire provide to participant's about their health and quality of life since treatment
Study NCT05564026 — intervention group
Intervention type: OTHER
Intervention: Tumor Specimen Collection
Description: Tumor DNA requested from the Biopathology Center
Study NCT05564026 — intervention group
Intervention type: OTHER
Intervention: Germline DNA Samples
Description: Germline DNA specimens requested from the Biopathology Center or newly collected saliva
Study NCT05564026 — intervention group
Intervention type: PROCEDURE
Intervention: Blood Sample Collection
Description: Collection and storing of serum/plasma
Study NCT06563544 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FCV
Description: 90 minutes of FCV
Study NCT05811585 — intervention group
Intervention type: DEVICE
Intervention: ADEPT
Description: Adhesion Reduction Solution (4% icodextrin solution)
Study NCT05775003 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 8 week exercise training program - consisting of weight training and cardiovascular exercise
Study NCT05775003 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Exercise
Description: 8 week exercise training program - consisting of weight training and cardiovascular exercise
Study NCT06212271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: See arm description.
Study NCT06212271 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: See arm description.
Study NCT06464848 — intervention group
Intervention type: OTHER
Intervention: Narrative identity task
Description: All participants will be asked to develop five personal narratives in response to different types of questions: trauma, transgression, negative memory, self-definition, and turning point. For each story, participants will be asked to provide details of where they were, who they were with, what happened and how they and others reacted, what happened, how they reacted and how others reacted (if at all).
Study NCT06060990 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: trace elements
Description: trace elements as biomarkers for response to systemic therapy in metastatic BTCs
Study NCT05665166 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
Description: Autologous CD34+ haematopoietic stem cells from MPS II patients will be genetically modified ex vivo using CD11b.IDS-ApoEII Lentiviral Vector (LV), a self-inactivating (SIN) LV expressing the human codon-optimized IDS gene tagged with ApoEII and regulated by a human CD11b myeloid-specific promoter. These transduced CD34+ HSCs will then be cryopreserved until the time of infusion back to the patients
Study NCT05632315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMT
Description: Fecal Microbiota for Transplant, enema product (PMT-001) or Fecal Microbiota for Transplant, suspension product (PMT-002)
Study NCT05537792 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Knee/Ankle Prosthesis
Description: The intervention is an experimental robotic knee/ankle prosthesis that has been previously developed by the team. It is used to improve walking gait performance.
Study NCT04315246 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: radiolabeled DPTA-omburtamab
Description: Biological, radiolabeled DPTA-omburtamab
Study NCT06619210 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HL231 Dose 1/2/3/4
Description: HL231 Solution for Inhalation, dose 1/2/3 (Part A) , dose 2/4（Part B） single dose, oral inhalation by PARI BOY nebulizer
Study NCT06619210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HL231 Dose 1/2/3/4
Description: HL231 Solution for Inhalation, dose 1/2/3 (Part A) , dose 2/4（Part B） single dose, oral inhalation by PARI BOY nebulizer
Study NCT05449535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JYB1904
Description: Dosage form: injection, solution； Usage and dosage matching:dose 1, dose 2, dose 3, dose 4, dose 5; single-dose; subcutaneous injection in the deltoid region of the upper arm.
Study NCT05449535 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omalizumab
Description: Dosage form: injection, powder, lyophilized, for solution； Usage and dosage matching:dose 1; single-dose; subcutaneous injection in the deltoid region of the upper arm.
Study NCT05449535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JYB1904 Placebo
Description: Dosage form: injection, solution； Usage and dosage matching:dose 1, dose 2, dose 3, dose 4, dose 5; single-dose; subcutaneous injection in the deltoid region of the upper arm.
Study NCT04756583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Notification system
Description: Email and page notification sent to clinicians for patients at high-risk of mortality in 30 days and 6 months
Study NCT05754580 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High Dose Brachytherapy
Description: This technique involves transient insertion of a stronger (i.e. more active) source (Ir-192) into the prostate, with dose delivery over the course of several minutes followed by immediate removal.
Study NCT05754580 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereostatic Body Radiation Therapy
Description: ultra-hypofractionation radiation therapy.
Study NCT06547086 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial electrical stimulation with Temporal Interference (TES-TI)
Description: TES-TI uses specific electrode arrangement patterns to selectively stimulate the brain. Participants will wear an hdEEG (high density electroencephalography) cap which will allow intermittent periods of stimulation from TES-TI.
Study NCT06642155 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RESPONSIBLEPLAY© MTM-Based Intervention
Description: Participants in this group will receive a theory-based intervention using the Multi-theory Model (MTM) of health behavior change. The intervention includes participatory dialogue, behavioral confidence-building, and strategies to modify the physical and social environments. It also incorporates emotional transformation and practice for change. Sessions will be delivered in-person over three weeks, focusing on promoting responsible gambling behaviors.
Study NCT06642155 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Knowledge-Based Intervention
Description: Participants in this group will receive a knowledge-based intervention that provides information on gambling risks and responsible gambling strategies. The intervention consists of lectures and reading materials delivered in-person over three weeks. It focuses on raising awareness of gambling risks but does not include the behavioral change strategies used in the MTM-based intervention.
Study NCT06311435 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: RNA Biomarker Blood Test
Description: Blood will be collected into a PaxGene Blood tube for processing by sponsor
Study NCT06181357 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic lung volume reduction in 2 stages
Description: After the selection process, they will all be hospitalized in order to undergo an endoscopic lung volume reduction with Zephyr® valve under general anesthesia. In the experimental group, patients will be treated according to Limoges' treatment algorithm (2 stages)
Study NCT06181357 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Endoscopic lung volume reduction in 1 stage
Description: After the selection process, they will all be hospitalized in order to undergo an endoscopic lung volume reduction with Zephyr® valve under general anesthesia. In the control group, the entire lobe will be treated during one procedure
Study NCT05399017 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EZVent
Description: EZVent Ventilator System is designed for respiratory support in hospitalized mechanical ventilated patients. The Ventilator is designed to be used for adults patients. It is designed to be a stationary product suitable for service in hospitals, critical care situations to provide continuous positive pres- sure respiratory support to the patient. The ventilator met EDA, ISO 80601-2-12 requirements on essential performance of critical care ventilator and other applicable international standards.
Study NCT05225675 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ARGX-117
Description: Intravenous administration of ARGX-117
Study NCT05225675 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous administration of placebo
Study NCT06260943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Target Navigation Pilot Program
Description: Participants will meet with a navigator, in either English, Spanish or Creole, biweekly, in person or virtually, until the first treatment appointment and every three months after. Each session will last approximately one hour; depending on the needs identified, patients will be connected to appropriate institutional or community-based resources.
Study NCT06439589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS2398
Description: HRS2398: Tablets, 40mg/tablet, oral
Study NCT06439589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Adebrelimab (SHR-1316): injection, 600mg(12mL), intravenous infusion
Study NCT05483101 — intervention group
Intervention type: OTHER
Intervention: Alternative birth units
Description: Midwife-led alternative birth units are a new model of care in France in which the midwife is the primary health care professional caring for low-risk pregnant women, as opposed to those cared for by an obstetrician-led medical team. Accordingly, alternative birth units also provide a space within which midwives can practice to their fullest potential with more professional autonomy than in a traditional obstetric setting. These birth units emphasizes care that promotes normal physiologic pregnancy and labor and supports the natural ability of women to experience birth with minimum or no routine intervention.~Alternative birth units named Filière physiologique (FP) co-exist in the same building on the same site as a hospital or host obstetric unit. In the event a laboring women needs comprehensive emergency obstetric care, she can be transferred immediatly in a conventionnal birth room.
Study NCT06577519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vicagrel
Description: Vicagrel loading followed by Maintenance dose
Study NCT06577519 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clopidogrel
Description: Clopidogrel loading followed by Maintenance dose
Study NCT05843058 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: laughter yoga
Description: The effect of laughter yoga on psychologıcal wellness ın women wıth gynecologıcal cancer has been evaluated.
Study NCT05261334 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: contour augmentation
Description: early implant placement with contour bone augmentation
Study NCT05272696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel, cisplatin and Pembrolizumab combination
Description: Pembrolizumab in combination with Nab-paclitaxel and cisplatin as induction therapy
Study NCT05272696 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgery
Description: Patients with PR but the maximum diameter of tumor > 3cm or SD or PD can receive surgery directly.
Study NCT05272696 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Adjuvant Chemoradiotherapy
Description: After surgery, adjuvant Chemoradiotherapy or radiotherapy will be given for patients with high-risk factors.
Study NCT05272696 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Radical concurrent chemoradiotherapy
Description: Patients with PR and maximum tumor diameter ≤ 3cm or CR evaluated by MDT after 2 courses induction therapy can receive Radical concurrent chemoradiotherapy. Evaluation was performed 3 months after CRT. After MDT discussion, patients with high-risk factors need maintenance treatment.
Study NCT06619210 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: HL231 Dose 1/2/3/4
Description: HL231 Solution for Inhalation, dose 1/2/3 (Part A) , dose 2/4（Part B） single dose, oral inhalation by PARI BOY nebulizer
Study NCT04471935 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: At home Speech Hero therapy app
Description: Participants will be instructed to use the Speech Hero therapy app for three hours per week over a 4-week period.
Study NCT05484076 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: breastfeeding counseling
Description: A breastfeeding booklet will be created by the researchers by taking expert opinion. This booklet will explain everything about breastfeeding in five sessions.~At 34-38 weeks of pregnancy, the first interviews will be done face-to-face at the hospital. The second interview will be made face-to-face or online, depending on the conditions, in the first 1-5 days after the birth. Subsequent interviews (postpartum 1-4 weeks, postpartum 5-12 weeks, postpartum 13-24 weeks) will be held online. The scales used in the research will be applied twice, before and after the training.
Study NCT04972968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABBV-154
Description: Subcutaneous Injection
Study NCT04972968 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneous Injection
Study NCT04972968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glucocorticoid
Description: Oral Tablet
Study NCT04972968 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Glucocorticoid
Description: Oral Tablet
Study NCT05524818 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: the Computerized Adaptive Testing System of the Functional Assessment of Stroke (CAT-FAS)
Description: The CAT-FAS comprises 58 items. The items were selected from four well-known physical function measures for patients with stroke: 26 items from the Fugl-Meyer Assessment-Upper Limb, 11 items from the Fugl-Meyer Assessment-Lower Limb, 12 items from the Postural Assessment Scale for Stroke Patients, and 9 items from the Barthel Index. These items evaluate motor control, postural control, and activity of daily living functions in patients with stroke. The CAT-FAS assesses all these functions simultaneously. Results are automatically reported as Rasch scores. A higher score indicates greater physical functions. In the previous study, results indicated that the CAT-FAS had sufficient efficiency (\< 10 items on average), reliability (Rasch reliability ≥ 0.88), concurrent validity (Pearson r ≥ 0.91), and responsiveness (SRM ≥ 0.65) in persons with stroke.
Study NCT04536857 — intervention group
Intervention type: OTHER
Intervention: Biomarker assay
Description: Biomarker assay will be used to quantify levels of misfolded alpha-synuclein aggregates in cerebrospinal fluid from patients with Parkinson's disease, multiple system atrophy, progressive superanuclear palsy and controls.
Study NCT06008197 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finerenone
Description: Oral finerenone
Study NCT06008197 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching oral placebo
Study NCT06072677 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program
Description: The Healthy Minds Program is a 4-week mobile program to improve coping and emotion regulation skills. It includes 4 training modules corresponding to key pillars of wellbeing: awareness(focused attention/awareness of thoughts/emotions), connection (empathy, compassion, social connection), insight (clarity of identify/experience) and purpose (applying values/motivations). The Healthy Minds Program includes 2 introductory audio lessons and guided meditations, and each 1-week module includes 2 podcast lessons (5-7 minutes) with psychoeducation and practical examples, and 3 guided meditations relevant to the module topic, for a total of 10 lessons and 14 guided meditations.